Center for Tobacco Control Research and Education, University of California, San Francisco, CA, USA.
Clinical Pharmacology Research Program, Division of Cardiology, Zuckerberg San Francisco General Hospital, Department of Medicine, University of California, San Francisco, CA, USA.
Addiction. 2020 Jun;115(6):1149-1159. doi: 10.1111/add.14931. Epub 2020 Feb 6.
Relative pharmacological effects of e-cigarettes and cigarettes during 24 hours of ad-libitum use have not been described. In this study, 24-hour blood plasma nicotine concentrations and 48-hour subjective effects with use of cigarettes and e-cigarettes were measured among dual users.
Two-arm within-subject cross-over design with preferred e-cigarette or cigarette ad-libitum use over 48 hours.
Hospital research ward in San Francisco, California, USA.
Thirty-six healthy dual users of e-cigarettes and cigarettes (n = 8, 25% females).
Twenty-four-hour blood plasma nicotine and cotinine concentrations and 48-hour self-reported nicotine withdrawal symptoms and rewarding effects.
Analyses used analysis of variance (ANOVA)-based mixed models with order of product (e-cigarette or cigarette) and product type (combustible cigarette or type of e-cigarette) as fixed effects, and subject as a repeated effect. During a 24-hour period, e-cigarettes produced lower nicotine exposure than cigarettes for the majority of users, although 25% received more nicotine from e-cigarettes, which was predicted by more frequent e-cigarette use or greater dependence. Compared to cigarette smoking, nicotine exposure for variable-power tank users was similar, while cig-a-like (t = 2.71, P = 0.011, d = 0.745) and fixed-power tank users (t = 3.37, P = 0.002, d = 0.993) were exposed to less nicotine. Cigarettes were rated higher than e-cigarettes on some desirable subjective effects (e.g. psychological reward, t = 7.24 P < 0.001, d = 0.432), but withdrawal symptom reduction was comparable. No differences were found between e-cigarette types, but Bayes factors indicate that these measures were insensitive.
During a 24-hour period in a hospital setting in the United States, nicotine exposure for dual users of e-cigarettes and cigarettes was similar when using cigarettes or variable-power tank devices only but was lower for those using cig-a-like or fixed-power devices only. Despite lower nicotine levels, all types of e-cigarette were effective in preventing withdrawal symptoms. E-cigarettes were rated less rewarding than cigarettes.
电子烟与香烟在自主使用 24 小时期间的相对药理学效应尚未被描述。在这项研究中,我们在旧金山的一家医院研究病房中,测量了电子烟和香烟双重使用者在使用 48 小时内的 24 小时血浆尼古丁浓度和 48 小时主观效应。
双臂自身交叉设计,电子烟或香烟自主使用 48 小时。
美国加利福尼亚州旧金山的一家医院研究病房。
36 名电子烟和香烟双重使用者(n = 8,女性占 25%)。
24 小时血浆尼古丁和可替宁浓度,以及 48 小时内自我报告的尼古丁戒断症状和奖赏效应。
分析采用基于方差分析(ANOVA)的混合模型,以产品顺序(电子烟或香烟)和产品类型(可燃香烟或电子烟类型)为固定效应,以受试者为重复效应。在 24 小时期间,大多数使用者使用电子烟时尼古丁暴露水平低于香烟,但 25%的使用者从电子烟中摄入更多的尼古丁,这是由更频繁地使用电子烟或更高的依赖性预测的。与吸烟相比,可变功率罐用户的尼古丁暴露情况相似,而类似雪茄的电子烟(t = 2.71,P = 0.011,d = 0.745)和固定功率罐用户(t = 3.37,P = 0.002,d = 0.993)的尼古丁暴露水平较低。香烟在一些理想的主观效应上(如心理奖赏)的评分高于电子烟(t = 7.24,P < 0.001,d = 0.432),但戒断症状缓解程度相当。电子烟类型之间没有差异,但贝叶斯因子表明这些措施不敏感。
在美国一家医院的环境中,在 24 小时期间,仅使用香烟或可变功率罐设备时,电子烟和香烟双重使用者的尼古丁暴露情况相似,但仅使用类似雪茄或固定功率设备时,电子烟的尼古丁暴露情况较低。尽管尼古丁水平较低,但所有类型的电子烟都能有效预防戒断症状。电子烟的奖赏程度低于香烟。